Multidisciplinary Approach to High-Risk HR+/HER2- Breast Cancer Identification

Introduction

The June BC TALKS will feature five expert physicians: Prof. Michael Gnant (Austria), Prof. Marc Thill (Germany), Prof. Maria-João Cardoso (Portugal) and Prof. Giancarlo Pruneri (Italy).
This will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A

Objectives

• Share data on the latest data for abemaciclib for patients with HR+ HER2-breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice. It will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A